Hey mate, I'm assuming you were referencing the drug candidates and I'm not so sure that they do need to be fully approved before a sale. I think it would be ideal and provide a bigger sale amount, but it's not essential as Prometheus' PRA-023 is yet to be completed -
One of best parts of Incannex's offerings is that a number of the components of their formulations are already approved and/or have been in use for some time. What hasn't been done before is adding these components together for an even better effect -
"We know the drugs have effects on their own, we just needto demonstrate that there is a benefit to the combination."
Also, apologies for my lousy copy and paste on the previous post. I just realised that the writing on the pics is super small. It was taken from the Investor Presentation from December '22.
